+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 55Years
All Genders
Healthy Volunteers
ID07736586

Randomized, Double-Blind Study to Evaluate Safety and Body Effects of Oral HL40626S Tablets in Healthy Adults

Led by HighsLab Therapeutics Inc. · Updated on 2026-10-29

64

Participants Needed

2

Research Sites

12 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a Phase 1 clinical trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and immune response of HL40626S tablets in healthy adults aged 18 to 55. This study is randomized, double-blind, and placebo-controlled, designed to assess single and multiple ascending doses of the medication. The trial aims to gather important early data on how the drug behaves in the body and its potential effects in healthy participants. The study consists of two parts Part 1 involves giving participants a single oral dose of HL40626S or a placebo under fasting conditions in five escalating dose groups, with safety monitored closely before dosing the full group. Part 2 involves administering once-daily oral doses of HL40626S or placebo for 14 consecutive days across three escalating dose groups, with dose increases reviewed by an independent safety committee. Both parts include placebo groups to compare safety and tolerability. Participants will undergo safety assessments including monitoring for adverse events, vital signs, laboratory tests, physical exams, and ECGs from consent through up to 29 days after dosing depending on the part of the study. Pharmacokinetic measures like drug concentration in plasma will be collected up to five days after the single dose. The trial includes frequent visits for dosing and monitoring, aiming to define the safety profile of HL40626S in healthy adults over the study duration.

CONDITIONS

Brief Title

A Study of HL40626S Tablets in Healthy Adults

Research Team

A

Arockiaa P Aarthy Joseph, MBBS

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here